Streetbeat News

OGI

OrganiGram Holdings Inc.

https://www.organigram.ca

Industry

Drug Manufacturers - Specialty & Generic

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Open

1.50

Mkt cap

156M

Volume

493K

High

1.50

P/E Ratio

-0.80

52-wk high

2.91

Low

1.44

Div yield

N/A

52-wk low

1.19

Microsoft shares rise as the company reports better-than-expected Q1 2025 GAAP EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:05 pm

Canada's cannabis market is experiencing stagnation with nearly zero growth in 2024. Top producers like Village Farms, Tilray, Organigram, and Cronos are seeing shifts in market share. The flower segment remains crucial, while pre-rolls and vapes gain popularity. Companies are focusing on international expansion due to domestic market limitations.

Portfolio Pulse from Nicolás Jose Rodriguez

October 29, 2024 | 1:29 pm

Cannabis stocks, including Canopy Growth, Aurora Cannabis, SNDL, and OrganiGram, are experiencing a rally with positive momentum. Each stock shows promise, but their outlooks vary based on technical factors such as moving averages and resistance levels.

Portfolio Pulse from Rolando García

October 25, 2024 | 5:36 pm

Germany is emerging as a leader in the European cannabis market, with significant growth potential due to recent decriminalization. Companies like Village Farms International and Organigram Holdings are focusing on this market, leveraging EU GMP certification for international expansion. Canada faces profitability challenges due to high taxes, while Australia shows promise in non-combustible cannabis products.

Portfolio Pulse from Nicolás Jose Rodriguez

October 14, 2024 | 3:26 pm

Banzai has been granted an extension by the Nasdaq Hearing Panel to regain compliance with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:34 pm

Cannabis stocks are experiencing a surge in trading following a report that Vice President Harris is advocating for the legalization of marijuana.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 3:16 pm

The cannabis sector experienced mixed movements on September 26, 2024, with some stocks gaining and others losing. Notable gainers included Urban-gro, Cara Therapeutics, Scotts Miracle Gro, and OrganiGram Holdings. Meanwhile, 22nd Century Group and Eastside Distilling were among the notable losers.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 8:30 pm

On September 25, 2024, several cannabis-related stocks experienced significant price movements. Notable gainers included Choom Holdings, Leafbuyer Techs, and Corbus Pharmaceuticals, while Currenc Group and Canopy Growth were among the losers.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 8:30 pm

On September 20, 2024, several cannabis stocks experienced significant price movements. OrganiGram Holdings (NASDAQ:OGI) saw a 3.26% increase, while Corbus Pharmaceuticals (NASDAQ:CRBP) dropped 61.70%. Other notable movements include Village Farms Intl (NASDAQ:VFF) down 9.18% and GrowGeneration (NASDAQ:GRWG) down 5.12%.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 8:30 pm

InterCure Ltd. (NASDAQ:INCR) has shown resilience in H1 2024 with revenues surpassing estimates despite challenges. The company is guiding for double-digit sales growth in H2 2024 and plans to expand its product offerings. However, cash reserves have plummeted, and net debt has increased. The stock has dropped significantly but remains attractively valued.

Portfolio Pulse from Nicolás Jose Rodriguez

September 14, 2024 | 6:32 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.